{"product_id":"recombinant-paxillin-antibody-bha17103763","title":"Recombinant Paxillin Antibody","description":"\u003ch2\u003eOverview\u003c\/h2\u003e\n\u003cp\u003e Paxillin antibody supplied as a purified reagent for WB, ICC\/IF, IHC-P in Human samples. This product is a Recombinant rabbit monoclonal antibody (host: Rabbit; isotype: Rabbit IgG) intended for research use only.\u003c\/p\u003e\n\u003ch2\u003eKey elements and design rationale\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntibody identity:\u003c\/strong\u003e  Rabbit Monoclonal; host Rabbit; isotype Rabbit IgG; clone RM256.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFormat and purification:\u003c\/strong\u003e format: Purified; purity: Protein A purified from animal origin-free supernatant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpecies reactivity (reported):\u003c\/strong\u003e Human.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eApplications (listed):\u003c\/strong\u003e WB, ICC\/IF, IHC-P.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmunogen \/ epitope context:\u003c\/strong\u003e A peptide corresponding to the N-terminus of human Paxillin was used as the immunogen for this  Paxillin antibody..\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThese attributes help you align the antibody with the biological question (target state, sample type, and readout) while keeping interpretation grounded in appropriate controls.\u003c\/p\u003e\n\u003ch2\u003eBiological background\u003c\/h2\u003e\n\u003cp\u003e Paxillin is the intended antigen for this primary antibody. Reported biological context includes: This  Paxillin antibody reacts to human Paxillin. It may also react to mouse or rat Paxillin, as predicted by immunogen homology.\u003c\/p\u003e\n\u003ch2\u003eResearch relevance and current trends\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eSpatial and single-cell approaches: imaging-based and cytometry workflows increasingly quantify heterogeneity and relocalization rather than only bulk abundance.\u003c\/li\u003e\n  \u003cli\u003eInteraction-centric biology: IP-based enrichment and proteomics are widely used to define complexes, binding partners, and context-specific interactomes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCommon research applications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eWestern blot (WB): compare relative abundance\/isoform patterns across conditions and sample types; band shifts may reflect processing or post-translational modification.\u003c\/li\u003e\n  \u003cli\u003eImmunocytochemistry \/ immunofluorescence (ICC\/IF): assess subcellular distribution and stimulus-dependent relocalization; co-localization analysis can support pathway or organelle hypotheses.\u003c\/li\u003e\n  \u003cli\u003eIHC-P: commonly used to measure relative target levels or localization changes in the context of the experimental question.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAcross these readouts, differences in signal intensity, localization, or complex enrichment are typically interpreted alongside sample-matched controls and independent evidence to distinguish regulation from technical variation.\u003c\/p\u003e\n\u003ch2\u003eNotes for experimental interpretation\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eIsoforms, cleavage products, or post-translational modifications can alter apparent molecular weight and subcellular distribution; interpret bands and staining patterns in the context of expected biology and sample preparation.\u003c\/li\u003e\n  \u003cli\u003eSpecies differences and epitope conservation may affect binding; use matched positive controls and orthogonal evidence when comparing across organisms.\u003c\/li\u003e\n  \u003cli\u003eControl concepts: include appropriate isotype and secondary-only controls (for imaging), and consider genetic perturbations (knockout\/knockdown\/overexpression) or independent antibodies targeting distinct epitopes to strengthen conclusions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEpitope context is defined by the immunogen description; when available, align this with known domains, PTM sites, or family homology to anticipate potential cross-reactivity patterns. As a monoclonal antibody, binding is driven by a single epitope, which can support consistent recognition but may be sensitive to epitope masking by PTMs or conformational changes.\u003c\/p\u003e\n\u003c!-- Sources (internal):\n- UniProtKB entry (P49023) — UniProt Consortium — https:\/\/www.uniprot.org\/uniprotkb\/P49023\/entry\n- NCBI Gene search ( Paxillin) — NCBI — https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=+Paxillin\n- Ensembl search ( Paxillin) — Ensembl — https:\/\/www.ensembl.org\/Multi\/Search\/Results?q=+Paxillin\n- PubMed search ( Paxillin) — NLM — https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=+Paxillin\n- Reactome pathway search ( Paxillin) — Reactome — https:\/\/reactome.org\/content\/query?q=+Paxillin\n--\u003e","brand":"NSJ Bioreagents","offers":[{"title":"Antibody in PBS with 50% glycerol, 1% BSA and 0.09% sodium azide \/ 100 ul","offer_id":53043682443629,"sku":"R20277-0.1ML","price":439.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/get_image_453ad2e7-a92e-4f35-9c56-71ae89fc6542.jpg?v=1771934411","url":"https:\/\/www.ebiohippo.com\/products\/recombinant-paxillin-antibody-bha17103763","provider":"BioHippo","version":"1.0","type":"link"}